Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells

International Journal of Oncology

Volumn 43, Issue 6, 2013, Pages 1777-1786

  Viedma Rodriguez, Rubí ^a,b   Baiza Gutman, Luis Arturo ^b   García Carranća, Alejandro ^b   Moreno Fierros, Leticia ^b   Salamanca Gómez, Fabio ^a   Arenas Aranda, Diego ^a  

^a Century XXI   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Apoptosis; BIK; Breast cancer; Tamoxifen

Indexed keywords

CASPASE; PROTEIN BAK; PROTEIN BAX; PUMA PROTEIN; SMALL INTERFERING RNA; TAMOXIFEN;

APOPTOSIS; ARTICLE; BIK GENE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MCF-7 CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TAMOXIFEN;

EID: 84891909628     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2127     Document Type: Article

References (27)

1. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
2. Zhao X, Wang L, Sun Y, et al: The reticulum (ER)-target protein Bik induces Hep3B cell apoptosis by the depletion of the ER Ca 2+ stores. Mol Cell Biochem 312: 33-38, 2008.
3. Lan KL, Yen SH, Liu RS, Shih HL, Tseng FW and Lan KH: Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer. Clin Exp Metastasis 24: 461-470, 2007.
4. Sturm I, Stephan C, Gillissn B, et al : Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 13: 619-627, 2006.
5. Gillissen B, Essmann F, Graupner V, et al: Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 22: 3580-3590, 2003.
6. Chinnadurai G, Vijayalingam S and Rashmi R: BIK, the founding member of the BH3-only family proteins: mecha nisms of cell death and role in cancer and pathogenic processes. Oncogene 27 (Suppl 1): S20-S29, 2008.
7. Chinnadurai G, Vijayalingam S and Gibson SB: BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene 27 (Suppl 1): S114-S127, 2008.
8. Zou Y, Peng H, Zhou B, et al: Systemic tumor suppression by the proapoptotic gene bik. Cancer Res 62: 8-12, 2002.
9. Garcia N, Salamanca F, Astudillo-de la Vega H, et al: A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. BMC Cancer 5: 93, 2005.
10. Real PJ, Sanz C, Gutierrez O, Pipaon C, Zubiaga AM and Fernandez -Luna JL: Transcriptional activation of the proapop totic bik gene by E2F proteins in cancer cells. FEBS Lett 580: 5905-5909, 2006.
11. Mathai JP, Germain M, Marcellus RC and Shore GC: Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 21: 2534-2544, 2002.
12. Boyd JM, Gallo GJ, Elangovan B, et al : Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921-1928, 1995.
13. Hur J, Bell DW, Dean KL, et al: Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Res 66: 10153-10161, 2006.
14. Nikrad M, Johnson T, Puthalalath H, Coultas L, Adams J and Kraft AS: The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim. Mol Cancer Ther 4: 443-449, 2005.
15. Monick MM, Powers LS, Butler NS and Hunninghake GW: Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure. J Immunol 171: 2625-2630, 2003.
16. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
17. Gottlieb E, Armour SM, Harris MH and Thompson CB: Mitochondrial membrane potential regulates matrix configura tion and cytochrome c release during apoptosis. Cell Death Differ 10: 709-717, 2003.
18. Hur J, Chesnes J, Coser KR, et al: The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc Natl Acad Sci USA 101: 2351-2356, 2004.
19. Prieto-Remon I, Sanchez-Carrera D, Lopez-Duarte M, Richard C and Pipaon C: BIK (NBK) is a mediator of the sensi tivity of Fanconi anemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents. Biochem J 448: 153-163, 2012.
20. Mebratu YA, Schwalm K, Smith KR, Schuyler M and Tesfaigzi Y: Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia. Am J Respir Crit Care Med 183: 1531-1538, 2011.
21. Fu Y, Li J and Lee AS: GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res 67: 3734-3740, 2007.
22. Weng SC, Kashida Y, Kulp SK, et al: Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther 7: 800-808, 2008.
23. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998.
24. Musgrove EA and Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9: 631-643, 2009.
25. Mandlekar S and Kong AN: Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6: 469-477, 2001.
26. Simonian PL, Grillot DA and Nunez G: Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2. Oncogene 15: 1871-1875, 1997.
27. Zhang H, Nimmer PM, Tahir SK, et al: Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 14: 943-951,